FindTrial
Sign In

Continuous Quality Improvement Based on the PDSA Cycle to Reduce Bronchopulmonary Dysplasia (BPD) in Extremely/Very Preterm Infants

Continuous Quality Improvement Based on the PDSA Cycle to Reduce Bronchopulmonary Dysplasia (BPD) in Extremely/Very Preterm Infants

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110447
Enrollment
Unknown
Registered
2025-10-14
Start date
2025-10-20
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary dysplasia(BPD)

Interventions

All premature infants born at the research center with a gestational age of less than 32 weeks:none

Sponsors

Chengdu Women's and Children's Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All live-born preterm infants with a gestational age <32 weeks born in the research center

Exclusion criteria

Exclusion criteria: no exclusion critieria

Design outcomes

Primary

MeasureTime frame
Mortality Rate;Incidence of BPD;Incidence of ROP;Incidence of NEC;Incidence of IVH;Red blood cell transfusion volume;Length of Stay ;—

Secondary

MeasureTime frame
Duration of Mechanical Ventilation;—

Countries

China

Contacts

Public ContactYiyong Fu

Chengdu Women's and Children's Central Hospital

xiaofoo000@126.com+86 158 2806 3621

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026